New Idylla NRAS Mutation Test (CE-IVD)
- Directly on 1 FFPE tissue section
- Detecting 18 relevant mutations
18Sep
News
18Sep
Idylla NRAS-BRAF Mutation Test receives CE-marking
Idylla™ offers complete CE-marked RAS testing for metastatic CRC.
18Sep
Idylla platform – real-time PCR based molecular diagnostics system
Idylla™, Biocartis’ fully automated, real-time PCR based molecular diagnostics system, is designed to offer fast and easy access to clinical molecular diagnostic information, anywhere and anytime.
18Sep
Biocartis Idylla BRAF Mutation Test
Introducing Biocartis Idylla – BRAF molecular results in as little as 90 minutes.
About 50 percent of all melanomas harbor mutations in the BRAF oncogene. Idylla™ BRAF Mutation Test detects BRAF mutations directly from FFPE tissue sections in 90 minutes with less than 2 minutes hands-on time.
06Sep
Study Reviewing 2,500 Performed Idylla Tests Shows Generation of Valid Results in 98.1% of Cases and Outperformance over Reference Methods
Press Release: Mechelen, Belgium, 27 June 2018